Poliomyelitis Completed Phase 2 Trials for Meningococcal polysaccharide vaccine group C (DB13890)

Back to Poliomyelitis

Also known as: Polio / Acute poliomyelitis, unspecified / Acute unspecified poliomyelitis / Polio acute / Acute poliomyelitis / Poliomyelitis NOS / Acute poliomyelitis (disorder) / Epidemic acute poliomyelitis (disorder) / Heine-Medin disease / Poliomyelitis (acute) / Poliomyelitis acute

Indication	Status	Phase
DBCOND0013769 (Poliomyelitis)	Completed	2

clinicaltrials.gov Identifier	Title	Purpose	Drugs
NCT00355121	Study of Menactra® in Children Aged 4 to 6 Years When Administered Concomitantly With a Fifth Dose of DAPTACEL®	Prevention	Bordetella pertussis filamentous hemagglutinin antigen (formaldehyde inactivated) (DB10788) Bordetella pertussis fimbriae 2/3 antigen (DB10790) Bordetella pertussis pertactin antigen (DB10789) Bordetella pertussis toxoid antigen (glutaraldehyde inactivated) (DB10787) Clostridium tetani toxoid antigen (formaldehyde inactivated) (DB10583) Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) (DB10584) Meningococcal polysaccharide vaccine group C (DB13890) Meningococcal polysaccharide vaccine group W-135 (DB13887) Meningococcal polysaccharide vaccine group Y (DB13888)
NCT01171989	Immunogenicity and Safety Study of GlaxoSmithKline Biologicals' GSK2202083A Vaccine Administered as a Booster Dose	Prevention	Bordetella pertussis filamentous hemagglutinin antigen (formaldehyde inactivated) (DB10788) Bordetella pertussis pertactin antigen (DB10789) Bordetella pertussis toxoid antigen (formaldehyde inactivated) (DB14388) Clostridium tetani toxoid antigen (formaldehyde inactivated) (DB10583) Corynebacterium diphtheriae (DB09877) Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) (DB10584) Haemophilus influenzae b polysaccharide-tetanus conjugate (DB15876) Hepatitis B Vaccine (Recombinant) (DB11627) Meningococcal polysaccharide vaccine group C (DB13890) Poliovirus type 1 antigen (formaldehyde inactivated) (DB10795) Poliovirus type 2 antigen (formaldehyde inactivated) (DB10796) Poliovirus type 3 antigen (formaldehyde inactivated) (DB10797) Streptococcus pneumoniae type 1 capsular polysaccharide antigen (DB10319) Streptococcus pneumoniae type 14 capsular polysaccharide antigen (DB10332) Streptococcus pneumoniae type 18c capsular polysaccharide antigen (DB10335) Streptococcus pneumoniae type 19f capsular polysaccharide antigen (DB10336) Streptococcus pneumoniae type 23f capsular polysaccharide antigen (DB10340) Streptococcus pneumoniae type 4 capsular polysaccharide antigen (DB10322) Streptococcus pneumoniae type 5 capsular polysaccharide antigen (DB10323) Streptococcus pneumoniae type 6b capsular polysaccharide antigen (DB10324) Streptococcus pneumoniae type 7f capsular polysaccharide antigen (DB10325) Streptococcus pneumoniae type 9v capsular polysaccharide antigen (DB10328)
NCT01090453	Study of GlaxoSmithKline Biologicals' GSK2202083A Vaccine in Healthy Infants	Prevention	Bordetella pertussis filamentous hemagglutinin antigen (formaldehyde inactivated) (DB10788) Bordetella pertussis pertactin antigen (DB10789) Bordetella pertussis toxoid antigen (formaldehyde inactivated) (DB14388) Clostridium tetani toxoid antigen (formaldehyde inactivated) (DB10583) Corynebacterium diphtheriae (DB09877) Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) (DB10584) Haemophilus influenzae b polysaccharide-tetanus conjugate (DB15876) Hepatitis B Vaccine (Recombinant) (DB11627) Meningococcal polysaccharide vaccine group C (DB13890) Poliovirus type 1 antigen (formaldehyde inactivated) (DB10795) Poliovirus type 2 antigen (formaldehyde inactivated) (DB10796) Poliovirus type 3 antigen (formaldehyde inactivated) (DB10797) Rotavirus vaccine (DB10276) Streptococcus pneumoniae type 1 capsular polysaccharide antigen (DB10319) Streptococcus pneumoniae type 14 capsular polysaccharide antigen (DB10332) Streptococcus pneumoniae type 18c capsular polysaccharide antigen (DB10335) Streptococcus pneumoniae type 19a capsular polysaccharide antigen (DB10337) Streptococcus pneumoniae type 19f capsular polysaccharide antigen (DB10336) Streptococcus pneumoniae type 23f capsular polysaccharide antigen (DB10340) Streptococcus pneumoniae type 3 capsular polysaccharide antigen (DB10321) Streptococcus pneumoniae type 4 capsular polysaccharide antigen (DB10322) Streptococcus pneumoniae type 5 capsular polysaccharide antigen (DB10323) Streptococcus pneumoniae type 6A capsular polysaccharide diphtheria CRM197 protein conjugate antigen (DB10296) Streptococcus pneumoniae type 6b capsular polysaccharide antigen (DB10324) Streptococcus pneumoniae type 7f capsular polysaccharide antigen (DB10325) Streptococcus pneumoniae type 9v capsular polysaccharide antigen (DB10328)
NCT00970307	Immunogenicity and Safety Study of GSK Biologicals' GSK2202083A Vaccine in Healthy Infants at 2, 3 and 4 Months of Age	Prevention	Bordetella pertussis filamentous hemagglutinin antigen (formaldehyde inactivated) (DB10788) Bordetella pertussis pertactin antigen (DB10789) Bordetella pertussis toxoid antigen (formaldehyde inactivated) (DB14388) Clostridium tetani toxoid antigen (formaldehyde inactivated) (DB10583) Corynebacterium diphtheriae (DB09877) Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) (DB10584) Haemophilus influenzae b polysaccharide-tetanus conjugate (DB15876) Hepatitis B Vaccine (Recombinant) (DB11627) Meningococcal polysaccharide vaccine group C (DB13890) Poliovirus type 1 antigen (formaldehyde inactivated) (DB10795) Poliovirus type 2 antigen (formaldehyde inactivated) (DB10796) Poliovirus type 3 antigen (formaldehyde inactivated) (DB10797)